NEW YORK & ZURICH, August 13, 2024--(BUSINESS WIRE)--Actuate, a leader in AI-powered threat detection software, announced today that it has partnered with LatticeFlow AI to accelerate security ...
Actuate's AI solutions are instrumental in enabling remote video guarding operations, allowing a handful of operators to effectively monitor thousands of cameras. Nathan Varn, Vice President of ...
As AI becomes an increasing part of our daily lives, people are starting to change the way they perform their daily tasks. The idea of incorporating AI into everyday activities is gradually ...
The company’s high-end AI chips help provide the processing power AI software needs to perform optimally. Cloud vendors and consumer internet companies are buying Nvidia graphics processing ...
Interest in artificial intelligence continues to surge, as Google searches over the past 12 months are at 92% of their all-time peak, but recent research suggests AI’s success could be its downfall.
Hiya, folks, welcome to TechCrunch’s regular AI newsletter. If you want this in your inbox every Wednesday, sign up here. Say what you will about generative AI. But it’s commoditizing — or ...
AI exchange-traded funds are one way to invest in artificial intelligence. Here's a list of the best-performing AI ETFs this month. Many, or all, of the products featured on this page are from our ...
However, with the volume of data required to school AI, many models end up consuming other AI-generated data, which can in turn negatively affect the model as a whole. With AI both producing and ...
Actuate Therapeutics has won Food and Drug Administration orphan-drug designation for its lead investigational drug product in a group of rare cancerous tumors. Actuate on Wednesday said the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback